Envoy Medical Acclaim Implant Trial Hits Key Milestone
WHITE BEAR LAKE, Minn., April 22, 2026 Envoy Medical, Inc. announced a major milestone in its pivotal clinical trial...
AI drug discovery Alzheimer’s Disease artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
WHITE BEAR LAKE, Minn., April 22, 2026 Envoy Medical, Inc. announced a major milestone in its pivotal clinical trial...
SYDNEY, Australia, December 17, 2025 — Envoy Medical, Inc. has been granted a new Australian patent for its innovative...
WHITE BEAR LAKE, Minn., Dec. 10, 2025 — Envoy Medical announced the successful first set of activations in the...
White Bear Lake, Minnesota — November 20, 2025 — Envoy Medical Inc. (NASDAQ: COCH) announced the issuance of U.S....
November 18, 2025 — Austin, Texas — Envoy Medical, Inc. announced it has successfully enrolled its first 10 patients...
ST. PAUL, Minn., Oct. 8, 2025 — Envoy Medical, a pioneer in fully implanted hearing device technology, has received...
